News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Amol Akhade: BREAKING from China – HER2+ Bladder Cancer may have a new contender
Amol Akhade/hiranandanihospital.org
May 13, 2025, 08:20

Amol Akhade: BREAKING from China – HER2+ Bladder Cancer may have a new contender

Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, posted on X:

“BREAKING from China
HER2+ Bladder Cancer may have a new contender!
DV (Disitamab Vedotin) + Toripalimab
– Met BOTH primary endpoints:
OS
PFS
– Statistically significant
– Clinically meaningful benefit
– Works across HER2 levels (IHC 1+, 2+, 3+)
– Safe in cisplatin-unfit patients
– Manageable safety profile
484 patients | 74 centers | Phase 3 | RC48-C016
Full data at international meetings in 2025!
BLA filing coming soon.
After EV + Pembro set a new bar, DV + Tori may raise it further for HER2+ mUC.”

Bladder Cancer

More posts featuring Amol Akhade on OncoDaily.

Amol Akhade bladder cancer cancer disitamab vedotin HER2+ Bladder Cancer OncoDaily Oncology toripalimab
Special Coverage
Insight
May 13, 2025, 08:20
Amol Akhade: BREAKING from China - HER2+ Bladder Cancer may have a new contender
Blog
May 13, 2025, 08:10
Kim Stanbery: Celebrating Our Oncology Nursing Teams - One Superpower at a Time
Blog
May 13, 2025, 08:08
Sachin H. Jain Reflects on the Realities of Strategic Planning in Healthcare Leadership
Science
May 13, 2025, 07:56
Case of The Month #40 - PSOGI
Blog
May 13, 2025, 07:54
Hathal Haddad Highlights Christopher Dürrbeck’s ESTRO-Elekta Award
Science
May 13, 2025, 07:50
Haimanot Kasahun Shares Study on Pain Outcomes After Radiotherapy in Ethiopian Cancer Patients
Drugs
May 13, 2025, 07:49
Martin Makary: Why Are Drug Prices Up to 12 Times Higher in the United States Than in Europe?
Blog
May 13, 2025, 07:38
Creating 100% Smoke-Free Environments Is Key to Protecting Health and Save Lives - UICC
Science
May 13, 2025, 07:36
Arden Baylink: Please consider donating to our work and help us prevent stomach cancer before it starts!
Insight
May 13, 2025, 07:27
Agenus Shared Q1 2025 Financial Results and Immuno-Oncology Pipeline Updates
Blog
May 13, 2025, 07:25
We Sincerely Thank and Deeply Appreciate OncoDaily's Support for Featuring Our Recent Conference - Medibridge Global Academy
Science
May 13, 2025, 07:25
Francisco Esteva: New Study Shows that BSO Markedly Reduces Cancer Risk in BRCA1/2 Carriers